Consultant - Heart & Lung Transplant and Vascular Surgery, Artemis Hospitals, Gurgaon
Part 11 of 13 in Pulmonary Hypertension - A Multidisciplinary Approach
Why Pulmonary Hypertension Causes Right Heart Failure Before Left Heart Failure
August 16, 2026
A frequently asked question in pulmonary hypertension is why the condition causes right ventricular failure rather than left ventricular failure, given that both ventricles are part of the same circulatory system. The answer lies in the fundamentally different design of the two ventricles.
The right ventricle is a volume-handling ventricle - it is not designed to cope with pressure overload. Its crescent, or biconvex, shape is the most efficient architecture for accumulating and ejecting large volumes of blood. This means the right ventricle can be loaded with a considerable amount of volume and will not fail, because volume is exactly what it is built to handle. But when it is instead subjected to a pressure overload, as happens in pulmonary hypertension, the right ventricle initially hypertrophies to compensate. Beyond a critical threshold, however, it simply fails.
The left ventricle, by contrast, is a pressure-handling ventricle. It is thick-walled and built specifically to generate high systolic pressure to drive blood around the body. Hypertrophy in response to pressure load is a well-tolerated, even expected, compensation in the left ventricle.
This is why pressure overload from pulmonary hypertension causes right ventricular failure far earlier than any effect on the left ventricle: the right ventricle is intrinsically a volume ventricle, not a pressure ventricle, and pulmonary hypertension imposes exactly the kind of load it was never built to tolerate.
This guide is based on a live Jivo Masterclass — Dr. Biswarup Purkayastha taught doctors across Africa on August 16, 2026.
FROM THE LIVE Q&A
Dr. Innocent Nzili
What is the PVR threshold for starting medical therapy in pulmonary hypertension?
Dr. Biswarup Purkayastha
Any mean pulmonary artery pressure greater than 20 mmHg combined with a pulmonary vascular resistance greater than 2 Wood units should be started on therapy — at minimum, a PDE5 inhibitor plus an endothelin receptor antagonist as double therapy. If the patient remains symptomatic, we add a prostacyclin analog to complete triple therapy. Escalating beyond triple therapy to sotatercept should only be considered after at least six months to a year of adequate triple therapy without sufficient response.
Book a Consultation with Dr. Biswarup Purkayastha
Book on WhatsAppOr message us on WhatsApp: +91 98182 98669
Frequently Asked Questions
What are the three major pharmacological pathways in pulmonary hypertension treatment?▼
First, PDE5 inhibition, to promote vascular relaxation via the cGMP pathway. Second, soluble guanylate cyclase stimulation, to address back-pressure and encourage vasodilation. Third, endothelin receptor blockade, to retard smooth muscle cell hypertrophy and reduce pulmonary vascular resistance. Sotatercept adds a fourth, distinct pathway — anti-proliferative inhibition of activin signalling — which addresses the underlying vascular remodelling rather than just haemodynamics.
Why does pulmonary hypertension cause right ventricular failure rather than left ventricular failure initially?▼
The right ventricle is a volume-handling ventricle, not designed for pressure overload — you can load it with considerable volume and it won't fail, because volume is its domain. But impose a pressure overload, as in pulmonary hypertension, and it hypertrophies to compensate before eventually failing. The left ventricle is a pressure-handling ventricle, built for exactly that load. That's why pulmonary hypertension causes right heart failure long before it affects the left.
What is the mechanism of pulmonary hypertension in HIV?▼
Two mechanisms operate together. Viral proteins cause stiffness in the lung's interstitial tissue, which physically compresses the pulmonary blood vessels. At the same time, the immunocompromised state associated with HIV promotes smooth muscle hyperplasia within the vessel walls, narrowing the lumen from within. It's the combination of external compression and internal luminal narrowing that drives HIV-associated pulmonary hypertension.
Why is P2 loud in pulmonary hypertension?▼
The pulmonary valve opens against a high-pressure circuit, so when it closes, it's slammed shut by that elevated pressure — a forceful, rapid closure that produces the loud P2. It isn't the size of the valve that determines the loudness, it's the closing pressure. That's why even in conditions like tetralogy of Fallot, where pulmonary stenosis would normally produce a soft P2, elevated pulmonary arterial pressure from collateral flow can still produce a loud P2 despite the outflow obstruction.
What antihypertensives are safe in pregnancy?▼
After the first trimester, amlodipine and other calcium channel blockers are reasonably safe. For eclampsia or hypertension specifically during pregnancy, the preferred agent is a direct alpha agonist, such as prazosin.
Why is the right ventricle described as a volume-handling ventricle?▼
The right ventricle's crescent, or biconvex, shape is the most efficient architecture for accumulating and ejecting large volumes of blood, meaning it can be loaded with considerable volume without failing.
How does the right ventricle initially respond to the pressure overload of pulmonary hypertension?▼
When subjected to a pressure overload, the right ventricle initially hypertrophies to compensate, though beyond a critical threshold it simply fails.
Why does the left ventricle tolerate pressure better than the right ventricle?▼
The left ventricle is thick-walled and built specifically to generate high systolic pressure, so hypertrophy in response to pressure load is a well-tolerated, even expected, compensation there.
What is the underlying reason pulmonary hypertension affects the right side of the heart first?▼
Pulmonary hypertension imposes a pressure load, and the right ventricle is intrinsically a volume ventricle rather than a pressure ventricle, so it fails under this kind of load far earlier than the left ventricle does.
In This Series: Pulmonary Hypertension - A Multidisciplinary Approach
- 1.Pulmonary Hypertension
- 2.What Is Pulmonary Hypertension? The Updated Diagnostic Threshold
- 3.The Five WHO Groups of Pulmonary Hypertension Explained
- 4.Recognising Pulmonary Hypertension: Symptoms, Comorbidities and Clinical Signs
- 5.Why Echocardiography Cannot Diagnose Pulmonary Hypertension
- 6.Risk Stratification in Pulmonary Hypertension: What Low-Risk Disease Looks Like
- 7.The Three Pharmacological Pathways in Pulmonary Hypertension Treatment
- 8.Double and Triple Combination Therapy for Pulmonary Hypertension
- 9.Sotatercept: A New Treatment Paradigm for Pulmonary Arterial Hypertension
- 10.Pulmonary Endarterectomy: Surgical Treatment for CTEPH
- 11.Why Pulmonary Hypertension Causes Right Heart Failure Before Left Heart Failure
- 12.Pulmonary Hypertension in HIV: Mechanism and Management
- 13.Managing Pulmonary Hypertension in Pregnancy: Safe Antihypertensive Medications